Clinical Trial Update: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of everolimus and vatalanib in patients with advanced solid tumors, including several neuroendocrine and other cancers;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrinoma
• Gastrointestinal Carcinoid Tumor
• Glucagonoma
• Insulinoma
• Melanoma
• Non-small Cell Lung Cancer
• Pancreatic Polypeptide Tumor
• Pheochromocytoma

Drugs mentioned

• Everolimus (everolimus)
• Vatalanib (vatalanib)

Snippet

Sponsor: Mayo Clinic | Conditions: Gastrinoma, Glucagonoma | Phase 1 | Status: COMPLETED